1 – 41 of 41
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change
2024) In International Journal of Cancer(
- Contribution to journal › Article
- 2023
-
Mark
Effects of tamoxifen on normal breast tissue histological composition : Results from a randomised six-arm placebo-controlled trial in healthy women
(
- Contribution to journal › Article
-
Mark
Side effects of low-dose tamoxifen : results from a six-armed randomised controlled trial in healthy women
(
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
(
- Contribution to journal › Article
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
(
- Contribution to journal › Article
- 2022
-
Mark
Postmenopausal overweight and breast cancer risk; results from the KARMA cohort
(
- Contribution to journal › Article
-
Mark
Interval breast cancer is associated with interferon immune response
(
- Contribution to journal › Article
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
(
- Contribution to journal › Article
- 2021
-
Mark
Association between breast cancer risk and disease aggressiveness : Characterizing underlying gene expression patterns
(
- Contribution to journal › Article
-
Mark
Low-Dose Tamoxifen for Mammographic Density Reduction : A Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
(
- Contribution to journal › Article
-
Mark
Breast cancer risk factors and survival by tumor subtype : pooled analyses from the Breast Cancer Association Consortium
2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(4). p.623-642(
- Contribution to journal › Article
-
Mark
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
(
- Contribution to journal › Article
- 2020
-
Mark
The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival : the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening
(
- Contribution to journal › Article
- 2019
-
Mark
Psychiatric disorders and cardiovascular diseases during the diagnostic workup of potential breast cancer : a population-based cohort study in Skåne, Sweden
(
- Contribution to journal › Article
-
Mark
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
(
- Contribution to journal › Article
- 2018
-
Mark
Long-term exposure to insulin and volumetric mammographic density : Observational and genetic associations in the Karma study
(
- Contribution to journal › Article
-
Mark
Feasibility of reusing time-matched controls in an overlapping cohort
(
- Contribution to journal › Article
- 2017
-
Mark
Cohort Profile : The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)
(
- Contribution to journal › Article
-
Mark
PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients
(
- Contribution to journal › Article
- 2016
-
Mark
Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues
(
- Contribution to journal › Article
-
Mark
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
2016) In Nature Genetics(
- Contribution to journal › Article
-
Mark
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
(
- Contribution to journal › Article
-
Mark
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
(
- Contribution to journal › Article
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
(
- Contribution to journal › Article
-
Mark
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
(
- Contribution to journal › Article
- 2015
-
Mark
Exome sequencing of contralateral breast cancer identifies metastatic disease
(
- Contribution to journal › Article
-
Mark
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
(
- Contribution to journal › Article
- 2014
-
Mark
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
(
- Contribution to journal › Article
- 2013
-
Mark
Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study
(
- Contribution to journal › Article
-
Mark
Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
(
- Contribution to journal › Article
-
Mark
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study
(
- Contribution to journal › Article
- 2010
-
Mark
Diagnostic work-up of contralateral breast cancers has not improved over calendar period
(
- Contribution to journal › Article
- 2009
-
Mark
No evidence that GATA3 rs570613 SNP modifies breast cancer risk
(
- Contribution to journal › Article
- 2004
-
Mark
Familial risk of cancer : data for clinical counseling and cancer genetics
(
- Contribution to journal › Article
-
Mark
Familial risk of urological cancers : data for clinical counseling
(
- Contribution to journal › Article
- 2002
-
Mark
Cancer risks in first-generation immigrants to Sweden
(
- Contribution to journal › Article